PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsWomen with BRCA mutations have lower ovarian reserve

BioNews

Women with BRCA mutations have lower ovarian reserve

Published 7 May 2021 posted in News and appears in BioNews 1094

Author

Anna Wernick

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

Breast cancer susceptibility genes influence the length of some women's fertile period, according to a global meta-analysis…

Breast cancer susceptibility genes (BRCA1 and BRCA2) influence the length of some women's fertile period, according to a global meta-analysis.

There have been conflicting results from studies of how BRCA mutations influence anti-Müllerian hormone (AMH) levels, which is used as an indicator of egg reserves. While some have found that the BRCA1 mutation lower AMH levels (see BioNews 848), others have failed to reproduce this. Now, an international group of scientists including some from Yale School of Medicine, Connecticut, report that BRCA1 but not BRCA2 mutations reduce AMH levels.

Professor Kutluk Oktay, director of Laboratory of Molecular Reproduction and Fertility Preservation at Yale, and study leader, said, 'These results can translate into a ten-year shortening of reproductive life period in these women, which means that women with BRCA mutations should be vigilant about completing childbearing early and/or considering fertility preservation if delaying childbearing.' 

Professor Oktay and colleagues investigated a large cohort of women with known BRCA status. They used five published datasets from which they were able to analyse the data from 824 women for the cohort study. Of these, 246 carried a BRCA1 and/or BRCA2 mutation while 578 were negative. The majority of the BRCA mutation carriers also had breast cancer. 

The average level of AMH in the serum of BRCA1/2 carriers was 2.04 ng/mL versus 3.36 ng/mL in noncarriers. This was significantly lower after adjusting for age, smoking status, and oral contraceptive use. However, while the mean level of AMH was significantly lower in the women with just BRCA1 mutations versus controls, the same was not true for BRCA2 carriers. 

'Although this meta-analysis could not demonstrate lower AMH levels in BRCA2 mutation carriers, this could be due to smaller sample size for the BRCA2 population,' Professor Oktay added. 

Additionally, the results of this analysis may be influenced by the fact that most of the women with BRCA mutations also had breast cancer. Importantly, chemotherapy can also influence ovarian reserve. Therefore, further analyses in woman with BRCA mutations without breast cancer must be conducted.

Professor Oktay concluded, 'Cancer is a disease of ageing and these studies will not only help with future fertility counselling for women carrying DNA repair gene mutations but... may also unravel the mechanisms of ageing in general.'

The study was published in Journal of Clinical Oncology.

Sources and References

  • 23/04/2021
    Journal of Clinical Oncology
    Association of germline BRCA pathogenic variants with diminished ovarian reserve: A meta-analysis of individual patient-level data
  • 06/05/2021
    Helio
    Certain women with BRCA variants may face ’10-year shortening of reproductive life period'

Related Articles

PET BioNews
News
28 January 2022 • 2 minutes read

BRCA genes linked to prostate and pancreatic cancer

by Georgia Stimpson

BRCA gene mutations have been linked to cancers, including prostate and breast cancer in men, in the largest study to date...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
20 August 2021 • 2 minutes read

BRCA2 DNA repair errors implicated in infertility

by Dr Molly Godfrey

BRCA2 mutations may be implicated in infertility, as well as increasing cancer risk, according to new research...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Reviews
10 May 2021 • 4 minutes read

Podcast Review: 'Will Cancer Make Me Infertile?' – That cancer conversation

by Beatrice Costa

Several studies have shown that cancer treatments, such as chemotherapy and radiotherapy, can have temporary or even permanent effects on fertility by damaging the ovaries or testis...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 September 2020 • 2 minutes read

BRCA-associated breast cancer risk may be influenced by the woman's genome

by Dr Laura Riggall

Women with high risk single-gene variants in the BRCA gene may have a lower risk of developing breast cancer than previously reported...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 February 2017 • 3 minutes read

BRCA testing not offered to enough high-risk patients

by Dr Hannah Somers

A study has indicated that US doctors may not be recommending genetic testing to a sufficient number of high-risk breast cancer patients...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
25 April 2016 • 2 minutes read

BRCA1 mutation linked to reduced egg reserves

by Dr Katie Howe

Women with a mutation in the breast-cancer susceptibility gene BRCA1 may have reduced numbers of eggs left in their ovaries, according to a study led by Australian scientists...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« First stage of human embryo development created with lab-grown stem cells

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Common virus may be cause of recent hepatitis cases in children

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

1 August 2022 • 2 minutes read

CRISPR genome editing treatments may raise cancer risk

1 August 2022 • 2 minutes read

Differences in IVF-conceived children's size disappear by adolescence

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856